Mice that are already infected with the pathogen that causes Lyme disease appear to facilitate the spread of a lesser-known but emerging disease, babesiosis, into new areas. Research led by the Yale School of Public Health and published Dec. 29 in the journal PLOS ONE used laboratory experiments, mathematical models, and fieldwork data to find that mice infected with the agent that causes Lyme disease (Borrelia burgdorferi) are at increased risk for also transmitting Babesia microti, the pathogen responsible for babesiosis, and could be enhancing the geographic spread of this emerging disease. Both diseases are transmitted to humans through the bite of infected black-legged ticks (Ixodes scapularis).
The finding provides a possible answer as to why human babesiosis is only emerging in areas where Lyme disease is well established, says Maria Diuk-Wasser, senior author of the study, who performed the research in collaboration with Peter Krause's and Durland Fish's research groups while she was assistant professor at the Yale School of Public Health. Diuk-Wasser, who maintains an adjunct position and active collaboration with the Yale School of Public Health, is an associate professor at Columbia University. Other study collaborators were at the Yale School of Medicine, Tufts Medical Center, and the Royal Melbourne Institute of Technology.
"Ticks and natural hosts are commonly co-infected in nature, so understanding how these pathogens may influence each other's abundance and distribution is key for public health," Diuk-Wasser says. "We found that B. burgdorferi and B. microti co-occur in ticks more frequently than expected, resulting in enhanced human exposure to multiple infections that can cause more severe symptoms and sometimes make diagnosis more difficult."
Ninety-five percent of all Lyme disease cases are reported from 14 states (primarily on the East Coast and in the Midwest), and there are approximately 30,000 new cases reported each year. Babesiosis is found in similar regions, but 95 percent of cases are concentrated in the seven "core" Lyme disease states (Connecticut, Massachusetts, New Jersey, New York, Rhode Island, Minnesota and Wisconsin). About 1,000 new cases of babesiosis are reported annually.
While the two diseases share some of the same symptoms, babesiosis is potentially fatal in immunocompromised patients and can be transmitted through blood transfusions in addition to tick bites, posing an additional public health threat.
Refined mathematical models may allow scientists to better predict areas that are at risk for B. microti expansion and to assess whether methods to reduce B. burgdorferi infection in ticks and mice may simultaneously reduce B. microti infection, Diuk-Wasser says.
Source: Yale University
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.